欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/V/0125/001
药品名称
Triquest
活性成分
SULFADIAZINE 333.0 mg/ml
TRIMETHOPRIM 67.0 mg/ml
剂型
Oral suspension
上市许可持有人
Alfasan Nederland B.V. Netherlands
参考成员国 - 产品名称
Sweden (SE)
Triquest Vet
互认成员国 - 产品名称
Norway (NO)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Estonia (EE)
Hungary (HU)
Germany (DE)
Bulgaria (BG)
Belgium (BE)
Triquest 333 mg/ml + 67 mg/ml
Cyprus (CY)
Netherlands (NL)
Czechia (CZ)
Luxembourg (LU)
Romania (RO)
Iceland (IS)
Slovakia (SK)
Ireland (IE)
Slovenia (SI)
Austria (AT)
Croatia (HR)
France (FR)
TRIQUEST 333 MG/ML + 67 MG/ML SUSPENSION BUVABLE POUR CHEVAUX
United Kingdom (Northern Ireland) (XI)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
许可日期
2024/05/08
最近更新日期
2025/01/17
药物ATC编码
QJ01EW10 sulfadiazine and trimethoprim
申请类型
TypeLevel1:
food
TypeLevel2:
Pharmaceutical
TypeLevel3:
Other Generic application Art 13.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase